Debiopharm
Genialis, Debiopharm Extend Cancer Biomarker Collaboration
The companies extended a deal to develop biomarkers predictive of the clinical benefit of Debiopharm's cancer drug candidates.
Cancer AI Startup Nucleai Raises $6.5M in Series A Financing
The initial investment is led by Debiopharm, which will collaborate with the Israeli startup to accelerate discovery of biomarkers for oncology drug response.
Caris Life Sciences Inks CDx Collaboration With Debiopharm
Caris will use its whole-transcriptome sequencing assay and Molecular Intelligence Trials service to identify patients for a phase II clinical trial.
Primerdesign, GenePOC Partner on Near-Patient Flu/RSV MDx
The firms intend to seek CE marking and US Food and Drug Administration clearance for the test.
BC Platforms Lands $10 Million Investment From Debiopharm, Tesi
wiss genomic data management company BC Platforms seeks to add a clinical component to its existing software this year.
Jan 11, 2017
GenePOC Instrument, Assays Get CE Mark
Jan 9, 2014
Jan 9, 2014
May 23, 2013
Cenix, Debiopharm Ink Biomarker ID Deal
May 23, 2013
Nov 15, 2012
Feb 3, 2011
Feb 3, 2011
Jan 18, 2011
Diagnoplex Gains Financing Extension
Apr 28, 2010